Results 171 to 180 of about 3,264,242 (368)

Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis

open access: yesBipolar Disorders, EarlyView.
ABSTRACT Background Recent advances now allow detection of brain‐specific proteins in blood, including neurofilament light chain (NfL), a marker of axonal pathology, and glial fibrillary acidic protein (GFAP), indicative of astrocytic activation. Given the evidence of astroglial pathology and neuronal dysfunction in bipolar disorder, and ongoing ...
Matthew J. Y. Kang   +15 more
wiley   +1 more source

Safety and tolerability of antipsychotics: focus on amisulpride

open access: yesDrug, Healthcare and Patient Safety, 2010
Mario F Juruena1, Eduardo Pondé de Sena2, Irismar Reis de Oliveira31Stress and Affective Disorders Programme, Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil ...
Mario F Juruena   +2 more
doaj  

Digital medication and patients' right of autonomy in Spain

open access: yesBioethics, Volume 39, Issue 5, Page 482-491, June 2025.
Abstract The progress the Internet has experienced in recent years has brought about huge changes and social transformation in all aspects of our lives. One such aspect greatly impacted has been our health, where we can talk about the existence of an ‘Internet of Medical Things’.
Salvador Pérez Álvarez
wiley   +1 more source

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression

open access: yesDrug, Healthcare and Patient Safety, 2020
Farid Chekani,1 Holly M Holmes,2 Michael L Johnson,1 Hua Chen,1 Jeffrey T Sherer,1 Rajender R Aparasu1 1Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204-5047, USA; 2Division of ...
Chekani F   +5 more
doaj  

Relevance of ecological momentary assessment for medication adherence in clinical settings: A precision psychiatry approach

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Background Medication non‐adherence is a leading cause of treatment failure in psychiatric populations. However, current studies highlight the lack of methodological guidance on medication assessments. Ecological Momentary Assessment (EMA), using smartphone‐based evaluations, shows promise for real‐time monitoring in everyday settings.
Valentine Chirokoff   +8 more
wiley   +1 more source

Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1

open access: hybrid, 1997
Lorraine Jones‐Brando   +4 more
openalex   +1 more source

Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents [PDF]

open access: green, 2009
Sun H. Kim   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy